US 12128092
Lyophilized factor IX formulations
granted A61KA61K38/4846A61K47/183
Quick answer
US patent 12128092 (Lyophilized factor IX formulations) held by BIOVERATIV THERAPEUTICS INC. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/4846, A61K47/183, A61K47/22, A61K47/26